Screener
Agilon Health AGL Q2 2026 earnings
Reported August 5, 2026 · After market close
Revenue$1.5BBeat by $43.9M
EPS$1.04Beat by $0.90
Revenue estimate$1.5B
EPS estimate$0.14
“Our second quarter results exceeded our expectations, demonstrating meaningful progress across agilon's strategic initiatives and reinforcing our confidence in the strength of our Total Care Model. We are raising our full-year 2026 outlook which reflects stronger burden of illness execution, favorable medical cost trends, and continued operating discipline. As I have engaged with our physician partners, payors, and the agilon team, I am even more convinced about the strength and long-term growth potential of the agilon model and its positioning at the center of where value-based care is going.”
Next report
Nov 3, 2026 (in 2 months)Revenue estimate$1.5B
EPS estimate-$1.22
Valuation & ratios
Segments
By product
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Agilon Health report Q2 2026 earnings?
- Agilon Health (AGL) reported Q2 2026 earnings on August 5, 2026 after market close.
- What were Agilon Health's Q2 2026 revenue and EPS?
- Agilon Health reported revenue of $1.5B and eps of $1.04 for Q2 2026.
- Did Agilon Health beat estimates in Q2 2026?
- Revenue beat the consensus estimate of $1.5B by $43.9M. EPS beat the consensus estimate of $0.14 by $0.90.
- How did Agilon Health's Q2 2026 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 7.2% from $1.4B a year earlier.
- Where can I find Agilon Health's Q2 2026 SEC filings?
- You can read the 8-K earnings release (0001628280-26-053328) and the 10-Q periodic report (0001628280-26-053355) directly on SEC EDGAR. The filing index links above go to sec.gov.
